SCIENTURE HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures
SCIENTURE HOLDINGS, INC. (SCNX) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures of 202 shares for the 12-month period ending 2022-12-31, per its 10-K filed 2024-04-22.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures · last filed 2024-04-22
- SCIENTURE HOLDINGS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for the quarter ending 2022-12-31 was -2.83K shares.
- SCIENTURE HOLDINGS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for the quarter ending 2022-09-30 was 0.00 shares.
- SCIENTURE HOLDINGS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for fiscal 2022 was 202.00 shares, a 99.47% decline from fiscal 2021.
- SCIENTURE HOLDINGS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for fiscal 2021 was 38.22K shares, a 14.64% increase from fiscal 2020.
- SCIENTURE HOLDINGS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for fiscal 2020 was 33.34K shares, a 1100.00% increase from fiscal 2019.
- SCIENTURE HOLDINGS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for fiscal 2019 was 2.78K shares, a 96.17% decline from fiscal 2018.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | -2.83K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-22 | -2.83K shares derived: sum of 2 quarters · filed 2024-04-22 | 202.00 shares 10-K · filed 2024-04-22 | 3.03K shares 10-K · filed 2023-03-27 | |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | 3.03K shares 10-Q · filed 2022-11-07 | |||
| 2022-06-30 | 3.03K shares 10-Q · filed 2022-07-25 | ||||
| 2021-12-31 | 38.22K shares 10-K · filed 2023-03-27 | ||||
| 2020-12-31 | 33.34K shares 10-K · filed 2022-03-28 | ||||
| 2019-12-31 | 2.78K shares 10-K · filed 2020-03-30 | ||||
| 2018-12-31 | 72.50K shares 10-K · filed 2020-03-30 | 435.00K shares 10-K · filed 2019-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |